INT17551
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
RESULTS: Immunohistochemical analysis revealed significantly increased expression of HLA-DR antigen in the glandular cells in eutopic and ectopic endometria, compared with materials from patients with adenomyoma and infertile patients. | |||||||||||||||
| |||||||||||||||
|
LPS, added experimentally to whole blood, enhanced HLA-DR expression on monocytes without further manipulation. | |||||||||||||||
| |||||||||||||||
|
Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes. | |||||||||||||||
| |||||||||||||||
|
In both groups the HLA-DR expression was significantly higher in the secretory phase than the proliferative or glandular and stroma cells. | |||||||||||||||
| |||||||||||||||
|
increased the expression of HLA-DR, particularly on CD14HIGH cells (CD14HIGH: + 263%; CD14LOW: + 87%) (Figure 7). | |||||||||||||||
| |||||||||||||||
|
Minor or irrelevant modifications in CD83 expression were observed (CPZ treated, irradiated cells versus irradiated control, Fig. 3A) and only a slight increase in HLA-DR expression was induced by CPZ under irradiation (Fig. 3B). | |||||||||||||||
| |||||||||||||||
|
Plasma concentrations of epinephrine, norepinephrine, cortisol, IL-6 and IL-10 as well as monocyte surface expression of HLA-DR and their ex vivo capacity to release TNF-alpha after LPS stimulation were measured perioperatively. | |||||||||||||||
| |||||||||||||||
|
CPZ, a known photosensitizer with photoallergenic and phototoxic properties, was tested with and without irradiation and the induced modulation of CD86, CD83 and HLA-DR expressions as well as cell viability were measured by flow cytometry and compared 48 h after treatment. | |||||||||||||||
| |||||||||||||||
|
Dose-dependent increases in CD86 and HLA-DR (but not CD83) expression were observed at radiation doses >1 J/cm2 UVA. | |||||||||||||||
| |||||||||||||||
|
Interestingly, photohaptenic properties were also described by Hino et al. [34] where SPFX treatment of THP-1 cells only resulted in enhanced HLA-DR but not CD86 or CD54 expression. | |||||||||||||||
| |||||||||||||||
|
Interestingly, photohaptenic properties were also described by Hino et al. [34] where SPFX treatment of THP-1 cells only resulted in enhanced HLA-DR but not CD86 or CD54 expression. | |||||||||||||||
| |||||||||||||||
|
The magnitude of that variability was investigated by measuring the expression of CD86, CD83 and HLA-DR on non-irradiated and irradiated, immature PBMDCs. | |||||||||||||||
| |||||||||||||||
|
As shown in Figure 8, HLA-DR expression on both CD14HIGH and CD14LOW monocytes was up-regulated by these pathogen-associated molecular patterns (PAMPs), particularly on CD14HIGH cells. | |||||||||||||||
| |||||||||||||||
|
As shown in Figure 8, HLA-DR expression on both CD14HIGH and CD14LOW monocytes was up-regulated by these pathogen-associated molecular patterns (PAMPs), particularly on CD14HIGH cells. | |||||||||||||||
| |||||||||||||||
|
In AAS, decreased HLA-DR expression already occurred during surgery for the CD14HIGH cells, earlier than that observed for the CD14LOW population and with a more pronounced effect. | |||||||||||||||
| |||||||||||||||
|
As shown in Figure 8, HLA-DR expression on both CD14HIGH and CD14LOW monocytes was up-regulated by these pathogen-associated molecular patterns (PAMPs), particularly on CD14HIGH cells. | |||||||||||||||
| |||||||||||||||
|
Furthermore, our data suggest that MARCH1 up-regulation by glucocorticoids might be a key element leading to reduced expression of HLA-DR on both CD14HIGH and CD14LOW monocytes. | |||||||||||||||
| |||||||||||||||
|
Increased HLA-DR expression by breast epithelial cells was observed in cases available for study. | |||||||||||||||
| |||||||||||||||
|
With an irradiation intensity of 1.7 mW/cm2 the HLA-DR expression first decreased (at 0.5 J/cm2) to nearly 75% of the non-irradiated control, and then increased in a dose-dependent manner up to 140% of control (Fig. 1C, white columns). | |||||||||||||||
| |||||||||||||||
|
Two studies have previously suggested that rs3129882 influences expression of HLA-DR and HLA-DQ. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.